Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

134.31USD
23 Jun 2017
Change (% chg)

$0.63 (+0.47%)
Prev Close
$133.68
Open
$133.50
Day's High
$134.56
Day's Low
$131.72
Volume
4,757,377
Avg. Vol
3,909,560
52-wk High
$135.18
52-wk Low
$94.42

Kaplan, Gilla 

Dr. Gilla Kaplan, Ph.D. serves as Independent director of the Company, Dr. Kaplan was appointed Director of the Global Health Program, Tuberculosis, at the Bill and Melinda Gates Foundation in January 2014. She previously served as Senior Advisor to the Global Health Program, Tuberculosis and member of the International Scientific Advisory Committee for the Global Health Program of the Bill and Melinda Gates Foundation. Dr. Kaplan was head of the Laboratory of Mycobacterial Immunity and Pathogenesis at The Public Health Research Institute Center at the New Jersey Medical School, Newark, New Jersey, where she was appointed full Member in 2002 and Assistant Director in 2006. Dr. Kaplan also was previously appointed, in 2005, Professor of Medicine at the University of Medicine and Dentistry of New Jersey. Prior to that, Dr. Kaplan was an immunologist in the Laboratory at Cellular Physiology and Immunology at The Rockefeller University in New York where she was an Associate Professor. Dr. Kaplan brings to her service as a director valuable scientific expertise and leadership skills from her distinguished career in medical research, including her current role as Director of the Global Health Program, Tuberculosis at the Bill and Melinda Gates Foundation and her past roles and experiences in the field of immunology.

Basic Compensation

Total Annual Compensation, USD 78,750
Restricted Stock Awards, USD 112,478
Long-Term Incentive Plans, USD --
All Other, USD 337,393
Fiscal Year Total, USD 528,621

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

16,526,200

Scott Smith

6,463,800

Mark Alles

12,192,400

Peter Kellogg

8,137,270

Terrie Curran

--

Michael Pehl

--
As Of  30 Dec 2016